InvestorsHub Logo
Followers 16
Posts 851
Boards Moderated 0
Alias Born 09/06/2007

Re: jakedogman1 post# 331962

Tuesday, 10/01/2019 11:58:50 PM

Tuesday, October 01, 2019 11:58:50 PM

Post# of 346071
Yes with Merck involved I’m sure there is strategy we aren’t privy to. They wouldn’t waste their time on a drug that was losing protection shortly after any potential approval. Marketing exclusivity can be used as a potential strategy. There are a number of ways to extend protection.

https://www.ajmc.com/journals/supplement/2016/how-drug-life-cycle-management-patent-strategies-may-impact-formulary-management/a636-article
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News